Several large-scale RCTs and meta-analyses have reported no statistically significant increase in pancreatitis risk associated with GLP-1 RAs
In the general population prescribed GLP-1s, stopping the medications comes with a rebound in weight gain and related metrics, such as blood pressure, cholesterol and blood sugar
Loss of GSH homeostasis as occurs in ageing, chronic inflammation, and metabolic disease shifts S-glutathionylation patterns and dysregulates the signalling networks that depend on them
The companies treating commercialisation as a cross-functional discipline rather than a downstream activity are quietly building the only moat that matters
GLP1 receptor agonists are a class of prescription medicines used to help regulate bloodsugar levels and may be prescribed for type 2 diabetes or weight management
Stay committed, be patient with your body, and remember that small lifestyle changes can make a big difference in your postpartum recovery journey